Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease

被引:21
|
作者
Lim, Wei Ling Florence [1 ,2 ]
Huynh, Kevin [3 ,4 ]
Chatterjee, Pratishtha [1 ,5 ,6 ]
Martins, Ian [2 ]
Jayawardana, Kaushala S. [3 ]
Giles, Corey [3 ]
Mellett, Natalie A. [3 ]
Laws, Simon M. [2 ,7 ,8 ]
Bush, Ashley I. [9 ]
Rowe, Christopher C. [9 ,10 ,11 ]
Villemagne, Victor L. [9 ,10 ,11 ,12 ]
Ames, David [13 ]
Drew, Brian G. [3 ,4 ]
Masters, Colin L. [9 ]
Meikle, Peter J. [3 ,4 ]
Martins, Ralph N. [1 ,2 ,5 ,6 ,14 ,15 ]
机构
[1] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
[2] Cooperat Res Ctr CRC Mental Hlth, Carlton, Vic, Australia
[3] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
[4] Monash Univ, Melbourne, Vic, Australia
[5] Macquarie Univ, Dept Biomed Sci, N Ryde, NSW, Australia
[6] KaRa Inst Neurol Dis, Macquarie Pk, NSW, Australia
[7] Edith Cowan Univ, Sch Med & Hlth Sci, Collaborat Genom Grp, Perth, WA, Australia
[8] Curtin Univ, Curtin Hlth Innovat Res Inst, Fac Hlth Sci, Sch Pharm & Biomed Sci, Bentley, WA, Australia
[9] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Heidelberg, Vic, Australia
[10] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia
[11] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia
[12] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia
[13] Natl Ageing Res Inst, Parkville, Vic, Australia
[14] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia
[15] Australian Alzheimers Res Fdn, Nedlands, WA, Australia
基金
英国医学研究理事会;
关键词
Aging; Alzheimer's disease; APOE epsilon 4; gender; lipid species; ALPHA-LINOLENIC ACID; MILD COGNITIVE IMPAIRMENT; FATTY-ACIDS; PHOSPHOLIPIDS; DEFICIENCY; ONSET; CONVERSION; PATTERN; BRAIN; RAFTS;
D O I
10.3233/JAD-191304
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Lipid metabolism is altered in Alzheimer's disease (AD); however, the relationship between AD risk factors (age, APOE epsilon 4, and gender) and lipid metabolism is not well defined. Objective: We investigated whether altered lipid metabolism associated with increased age, gender, and APOE status may contribute to the development of AD by examining these risk factors in healthy controls and also clinically diagnosed AD individuals. Methods: We performed plasma lipidomic profiling (582 lipid species) of the Australian Imaging, Biomarkers and Lifestyle flagship study of aging cohort (AIBL) using liquid chromatography-mass spectrometry. Linear regression and interaction analysis were used to explore the relationship between risk factors and plasma lipid species. Results: We observed strong associations between plasma lipid species with gender and increasing age in cognitively normal individuals. However, APOE epsilon 4 was relatively weakly associated with plasma lipid species. Interaction analysis identified differential associations of sphingolipids and polyunsaturated fatty acid esterified lipid species with AD based on age and gender, respectively. These data indicate that the risk associated with age, gender, and APOE epsilon 4 may, in part, be mediated by changes in lipid metabolism. Conclusion: This study extends our existing knowledge of the relationship between the lipidome and AD and highlights the complexity of the relationships between lipid metabolism and AD at different ages and between men and women. This has important implications for how we assess AD risk and also for potential therapeutic strategies involving modulation of lipid metabolic pathways.
引用
收藏
页码:303 / 315
页数:13
相关论文
共 50 条
  • [1] Lipids and Adipokines as Risk Factors for Alzheimer's Disease
    Warren, Matthew W.
    Hynan, Linda S.
    Weiner, Myron F.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 151 - 157
  • [2] Integrative network analysis identifies relationships between metabolomics, genomics, and risk factors for Alzheimer's disease
    Darst, Burcu F.
    Lu, Qiongshi
    Johnson, Sterling C.
    Engelman, Corinne D.
    [J]. GENETIC EPIDEMIOLOGY, 2018, 42 (07) : 695 - 695
  • [3] The relationship between Alzheimer's disease and vascular risk factors
    Chen, Xianghui
    Zhang, Weidong
    Qiao, Xiaohong
    Li, Youliang
    Duan, Hubin
    Sun, Pinglian
    [J]. FASEB JOURNAL, 2020, 34
  • [4] Risk factors for Alzheimer's disease
    Poduslo, SE
    Corder, EH
    Huang, R
    Cathcart, H
    Cheng, D
    Parker, G
    Smith, S
    Lanham, I
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S489 - S489
  • [5] Alzheimer's disease and risk factors
    Wen, GY
    [J]. JOURNAL OF FOOD AND DRUG ANALYSIS, 1998, 6 (02) : 465 - 476
  • [6] Risk factors for Alzheimer's disease
    Soininen, H.
    Solomon, A.
    Kivipelto, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S198 - S198
  • [7] Alzheimer's disease risk factors
    Barranco-Quintana, JL
    Allam, MF
    Del Castillo, A
    Navajas, RFC
    [J]. REVISTA DE NEUROLOGIA, 2005, 40 (10) : 613 - 618
  • [8] Risk factors for Alzheimer's disease
    Armstrong, Richard A.
    [J]. FOLIA NEUROPATHOLOGICA, 2019, 57 (02) : 87 - 105
  • [9] Vascular risk factors and the relationships between cognitive impairment and hypoperfusion in late-onset Alzheimer's disease
    Takahashi, Michio
    Oda, Yasunori
    Sato, Koichi
    Shirayama, Yukihiko
    [J]. ACTA NEUROPSYCHIATRICA, 2018, 30 (06): : 350 - 358
  • [10] Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
    Aschenbrenner, Andrew J.
    Petros, Jennifer
    McDade, Eric
    Wang, Guoqiao
    Balota, David A.
    Benzinger, Tammie Ls
    Cruchaga, Carlos
    Goate, Alison
    Xiong, Chengjie
    Perrin, Richard
    Fagan, Anne M.
    Graff-Radford, Neill
    Ghetti, Bernardino
    Levin, Johannes
    Weidinger, Endy
    Schofield, Peter
    Graber, Susanne
    Lee, Jae-Hong
    Chhatwal, Jasmeer P.
    Morris, John C.
    Bateman, Randall
    Hassenstab, Jason
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)